We're on the Move! Starting from May 28th, 2024, you will find all the details of our Recombumin® portfolio and Albumedix' services at our new online home, sartorius.com
Albumedix Media Library

Library

Welcome to Albumedix' Scientific Library - here you will find scientific papers authored and co-authored by some of Albumedix' leading scientists as well as our collaborators and partners.

Further to this, you'll gain access to our whitepapers, application notes, infographics and a selection of videos. Content spans general albumin research as well as application specific papers and presentations. 

Please provide your details to access this section.

To understand how we collect, store and use the information collected on the website please see our Privacy Policy.

CONTACT

Albumedix Ltd.
Mabel Street
The Meadows
Nottingham
NG2 3ED, United Kingdom
Tel: +44 115 9553379
info@albumedix.com

 

Albumedix - Dedicated to Better Health

Albumedix is a science-driven, biotechnology company focused on enabling the creation of superior biopharmaceuticals utilizing our albumin-based drug enhancing technologies. We partner with excellence to improve therapies for people with serious diseases. We are proud to be recognized as the world leader in recombinant human albumin with products and technologies used in clinical and marketed drugs by pharmaceutical companies worldwide. Headquartered in Nottingham, England with ~100 people all committed to improving patient quality of life. We are just as passionate about albumin and albumin-enabled therapies today as we were when we started 30 years ago.

 

Privacy | Cookies | Patent Portfolio

ALBUMEDIX, the ALBUMEDIX LOGO, DEDICATED TO BETTER HEALTH and marks such as RECOMBUMIN and VELTIS are trademarks of Albumedix. Albumedix© Copyright 2018

FOLLOW US